Atlas Trials

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

Clinical trial NCT05109195 · TERMINATED

Trial details

NCT number
NCT05109195
Sponsor
Janssen Research & Development, LLC
Status
TERMINATED
Study type
OBSERVATIONAL
Depressive Disorder, Major
Start date
2021-10-26
Primary completion
2022-10-19
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.